| Characteristic | Breast Cancer Patients n-218 | |
| Age | Mean ± S.D. | 49.68 ± 1.39 |
| Menstrual status | Perimenopausal | 83 (38%) |
|
| Postmenopausal | 135 (62%) |
| Family History | Positive | 47 (21.6%) |
|
| Negative | 169 (77.5%) |
|
| Unknown | 2 (0.9%) |
| Tumor type | Invasive Ductal Carcinoma | 213 (97.7%) |
|
| Invasive Lobular Carcinoma | 5 (2.3%) |
| Histological Grade | II | 165 (75.7%) |
|
| III | 51 (23.4%) |
|
| Unknown | 2 (0.9%) |
| Vascular Invasion | Positive | 145 (66.6%) |
|
| Negative | 71 (32.5%) |
|
| Unknown | 2 (0.9%) |
| Axillary Lymph Node Involvement | Positive | 161 (73.9%) |
| Negative | 55 (25.2%) | |
|
| unknown | 2 (0.9%) |
| Estrogen Receptor (ER) | Positive | 146 (66.7%) |
|
| Negative | 72 (33.3%) |
| Progesterone Receptor (PR) | Positive | 131 (60%) |
|
| Negative | 87 (40%) |
| Her2/neu Receptor | Positive | 66 (30.3%) |
|
| Negative | 142 (65.1%) |
|
| Unknown | 10 (4.6%) |